Caption Management, LLC Gossamer Bio, Inc. Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $201,564 - $298,286	23,882 New	23,882 $207,000
Q2 2020 Aug 14, 2020	SELL	$9.52 - $15.98 $380,800 - $639,200	-40,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $1.7 Million - $3.28 Million	-211,930 Reduced 84.12%	40,000 $406,000
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $4.04 Million - $5.66 Million	251,930 New	251,930 $4.23 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.